{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:32:39Z","timestamp":1774438359660,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003150","name":"Fonds Qu\u00e9b\u00e9cois de la Recherche sur la Nature et les Technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bcp.2014.04.017","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T22:30:27Z","timestamp":1399674627000},"page":"107-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A tamoxifen derivative, N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine, selectively targets P-glycoprotein-positive multidrug resistant Chinese hamster cells"],"prefix":"10.1016","volume":"90","author":[{"given":"Elias","family":"Georges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Laberge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.04.017_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","article-title":"Mechanisms of multidrug resistance in cancer","volume":"596","author":"Gillet","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0010","first-page":"389","article-title":"Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin","volume":"4","author":"Mechetner","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0015","first-page":"469","article-title":"Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines","volume":"9","author":"Chan","year":"1989","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0020","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/bjc.1996.655","article-title":"P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo","volume":"74","author":"Abe","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2014.04.017_bib0025","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1139\/o06-199","article-title":"Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1)","volume":"84","author":"Sharom","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0030","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1002\/jps.21770","article-title":"Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation","volume":"98","author":"Hassan","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bcp.2014.04.017_bib0035","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/38.9.1974900","article-title":"Expression of the multidrug resistance gene product (P-Glycoprotein) in human normal and tumor tissues","volume":"38","author":"Cordon-Cardo","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.bcp.2014.04.017_bib0040","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2014.04.017_bib0045","first-page":"749","article-title":"In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576","volume":"61","author":"Mistry","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0050","first-page":"129","article-title":"The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833","volume":"17","author":"Ehrlich","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0055","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1200\/JCO.2002.12.116","article-title":"Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918","volume":"20","author":"Kruijtzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0060","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.21666","article-title":"Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar\/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95): a trial of the Eastern Cooperative Oncology Group","volume":"106","author":"Friedenberg","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2014.04.017_bib0065","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cncr.22492","article-title":"A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer","volume":"109","author":"Gandhi","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2014.04.017_bib0070","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1158\/0008-5472.CAN-05-3322","article-title":"Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer","volume":"66","author":"Ludwig","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral sensitivity as a strategy against cancer multidrug resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bcp.2014.04.017_bib0080","first-page":"4730","article-title":"Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors","volume":"42","author":"Tsuruo","year":"1982","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0309-1651(86)90011-1","article-title":"Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines","volume":"10","author":"Warr","year":"1986","journal-title":"Cell Biol Int Rep"},{"key":"10.1016\/j.bcp.2014.04.017_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.1040880104","article-title":"Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity","volume":"88","author":"Bech-Hansen","year":"1976","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0095","first-page":"1195","article-title":"Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin","volume":"32","author":"Riehm","year":"1972","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0100","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1021\/bi034149+","article-title":"A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity","volume":"42","author":"Karwatsky","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2014.04.017_bib0105","doi-asserted-by":"crossref","unstructured":"Laberge RM, Ambadipudi R, Georges E. P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil. Arch Biochem Biophys 2009;491:53\u201360.","DOI":"10.1016\/j.abb.2009.09.012"},{"key":"10.1016\/j.bcp.2014.04.017_bib0110","doi-asserted-by":"crossref","unstructured":"Kudoh K, Kikuchi Y, Hiramatsu H, Hirata J, Yamamoto K, Kita T, et al. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin. Eur J Cancer 1997;33:122\u20138.","DOI":"10.1016\/S0959-8049(96)00345-0"},{"key":"10.1016\/j.bcp.2014.04.017_bib0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.canlet.2008.09.021","article-title":"Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene","volume":"274","author":"Ferguson","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2014.04.017_bib0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s002800050044","article-title":"N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs","volume":"45","author":"Brandes","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0125","doi-asserted-by":"crossref","unstructured":"Reyno L, Seymour L, Tu D, Dent S, Gelmon K, Walley B, et al. National Cancer Institute of Canada Clinical Trials Group Study, Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic\/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19. J Clin Oncol 2004;22:269\u201376.","DOI":"10.1200\/JCO.2003.04.075"},{"key":"10.1016\/j.bcp.2014.04.017_bib0130","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/bi00789a030","article-title":"Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane","volume":"10","author":"Fairbanks","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2014.04.017_bib0135","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2014.04.017_bib0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1073\/pnas.87.1.152","article-title":"Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies","volume":"87","author":"Georges","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2014.04.017_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1099-1271(199605)11:3<149::AID-BIO411>3.0.CO;2-Q","article-title":"Use of firefly luciferase for ATP measurement: other nucleotides enhance turnover","volume":"11","author":"Ford","year":"1996","journal-title":"J Biolumin Chemilumin"},{"key":"10.1016\/j.bcp.2014.04.017_bib0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0925-4439(97)00025-2","article-title":"ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2014.04.017_bib0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0925-4439(97)00026-4","article-title":"Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2014.04.017_bib0160","doi-asserted-by":"crossref","first-page":"16241","DOI":"10.3390\/ijms131216241","article-title":"Alterations in glutathione redox metabolism, oxidative stress, and mitochondrial function in the left ventricle of elderly zucker diabetic Fatty rat heart","volume":"13","author":"Raza","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bcp.2014.04.017_bib0165","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/ijms13033145","article-title":"Glutathione is a key player in metal-induced oxidative stress defenses","volume":"13","author":"Jozefczak","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bcp.2014.04.017_bib0170","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","article-title":"Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis","volume":"87","author":"Sinha","year":"2013","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2014.04.017_bib0180","doi-asserted-by":"crossref","first-page":"L1220","DOI":"10.1152\/ajplung.00371.2003","article-title":"Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis","volume":"286","author":"Panduri","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1097-0320(20001201)41:4<245::AID-CYTO2>3.0.CO;2-#","article-title":"Simultaneous detection of mitochondrial respiratory chain activity and reactive oxygen in digitonin-permeabilized cells using flow cytometry","volume":"41","author":"Pham","year":"2000","journal-title":"Cytometry"},{"key":"10.1016\/j.bcp.2014.04.017_bib0190","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.1016\/S0021-9258(18)42415-5","article-title":"The effect of antimycin A on mouse liver inner mitochondrial membrane channel activity","volume":"267","author":"Campo","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.04.017_bib0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-291X(92)92368-8","article-title":"Electron transport between cytochrome c and alpha tocopherol","volume":"188","author":"Maguire","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2014.04.017_bib0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0925-4439(97)00027-6","article-title":"Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2014.04.017_bib0205","first-page":"4025","article-title":"Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels","volume":"47","author":"Brandes","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0210","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.1074\/jbc.M510249200","article-title":"Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure","volume":"281","author":"Moreira","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.04.017_bib0215","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.bcp.2007.03.002","article-title":"Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)","volume":"73","author":"Heffeter","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0014-5793(89)81380-8","article-title":"Glycolysis in P-glycoprotein-overexpressing human tumor cell lines. Effects of resistance-modifying agents","volume":"247","author":"Broxterman","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2014.04.017_bib0225","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1023\/A:1026556119020","article-title":"Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma","volume":"11","author":"Belpomme","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0230","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/bjc.1993.189","article-title":"Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study","volume":"67","author":"Millward","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2014.04.017_bib0235","first-page":"4226","article-title":"In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833","volume":"51","author":"Boesch","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.017_bib0240","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.2004.07.048","article-title":"Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)","volume":"22","author":"Greenberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2014.04.017_bib0245","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V100.4.1224.h81602001224_1224_1232","article-title":"Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720","volume":"100","author":"Baer","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcp.2014.04.017_bib0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bjp.0701377","article-title":"Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein, Br J Pharmacol 122 (1997) 241-248. activity of human P-glycoprotein","volume":"122","author":"Watanabe","year":"1997","journal-title":"Br J Pharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:03:12Z","timestamp":1762095792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0006295214002597"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.04.017","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A tamoxifen derivative, N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine, selectively targets P-glycoprotein-positive multidrug resistant Chinese hamster cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}